Instil Bio, Inc. financial data

Symbol
TIL on Nasdaq
Location
3963 Maple Avenue, Suite 350, Dallas, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.47K % +69.2%
Debt-to-equity 47.2 % +39.1%
Return On Equity -55.6 % -3.33%
Return On Assets -37.8 % +5.98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.5M shares -95%
Common Stock, Shares, Outstanding 6.5M shares -95%
Entity Public Float 34.4M USD -88%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.5M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 6.5M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 20.7M USD -76.9%
General and Administrative Expense 45.9M USD -15.9%
Operating Income (Loss) -118M USD +38.9%
Nonoperating Income (Expense) -2.28M USD -256%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -156M USD +30.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -120M USD +35.6%
Earnings Per Share, Basic -18.4 USD/shares +59.3%
Earnings Per Share, Diluted -18.4 USD/shares +59.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.78M USD -68.8%
Marketable Securities, Current 141M USD -35%
Assets, Current 155M USD -29.8%
Property, Plant and Equipment, Net 133M USD -26.6%
Operating Lease, Right-of-Use Asset 1.71M USD -45.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 581K USD -81.3%
Assets 294M USD -27.9%
Accounts Payable, Current 1.22M USD -43.7%
Employee-related Liabilities, Current 2M USD -22.2%
Liabilities, Current 10.3M USD -44%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 2.02M USD -45.4%
Other Liabilities, Noncurrent 8K USD -95.1%
Liabilities 99.3M USD -11.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -627K USD +21.1%
Retained Earnings (Accumulated Deficit) -620M USD -23.9%
Stockholders' Equity Attributable to Parent 195M USD -34.2%
Liabilities and Equity 294M USD -27.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD +58.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 9.24M USD -36.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 6.5M shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.78M USD -70.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.73M USD +17.1%
Deferred Tax Assets, Valuation Allowance 127M USD +46.8%
Deferred Tax Assets, Gross 127M USD +44.3%
Operating Lease, Liability 3.69M USD -33.9%
Depreciation 4M USD -42%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119M USD +35.8%
Lessee, Operating Lease, Liability, to be Paid 3.96M USD -35.3%
Property, Plant and Equipment, Gross 138M USD -25.9%
Operating Lease, Liability, Current 1.67M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD -32.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.82M USD -8.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 271K USD -49.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.82M USD +43.1%
Deferred Tax Assets, Operating Loss Carryforwards 88.4M USD +51.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.34M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.22M USD -4.17%
Operating Lease, Payments 2.25M USD -18.2%
Additional Paid in Capital 816M USD +2.25%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 993K USD -44.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 17.9M USD -24%
Interest Expense 6.55M USD +160%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%